Daniel De Vos

Best Publications

• Phage Therapy in Clinical Practice: Treatment of Human Infections

  Elizabeth Kutter;Daniel De Vos;Guram Gvasalia;Zemphira Alavidze

  818
  Citations

• Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials

  Maya Merabishvili;Jean-Paul Pirnay;Gilbert Verbeken;Nina Chanishvili

  614
  Citations

• The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?

  Jean-Paul Pirnay;Daniel De Vos;Gilbert Verbeken;Maia Merabishvili

  345
  Citations

• Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study

  Unknown

  337
  Citations

• Pseudomonas aeruginosa population structure revisited

  Jean-Paul Pirnay;Florence Bilocq;Bruno Pot;Pierre Cornelis

  322
  Citations

• Use of siderophores to type pseudomonads: the three Pseudomonas aeruginosa pyoverdine systems.

  Jean Marie Meyer;Alain Stintzi;Daniel De Vos;Pierre Cornelis

  321
  Citations

• The Magistral Phage.

  Unknown

  319
  Citations

• Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report

  Unknown

  278
  Citations

• Quality and Safety Requirements for Sustainable Phage Therapy Products

  Jean-Paul Pirnay;Bob G. Blasdel;Laurent Bretaudeau;Angus Buckling

  271
  Citations

• Direct detection and identification of Pseudomonas aeruginosa in clinical samples such as skin biopsy specimens and expectorations by multiplex PCR based on two outer membrane lipoprotein genes, oprI and oprL.

  Danièle De Vos;Antonio Lim Jr.;Jean-Paul Pirnay;Marc Struelens

  257
  Citations

• Experimental phage therapy of burn wound infection: difficult first steps.

  Thomas Rose;Gilbert Verbeken;Daniel De Vos;Maia Merabishvili

  251
  Citations

• Metronidazole resistance in Helicobacter pylori.

  Youri Glupczynski;Alain Burette;Erik De Koster;Jean-François Nyst

  237
  Citations

• Molecular Epidemiology of Pseudomonas aeruginosa Colonization in a Burn Unit: Persistence of a Multidrug-Resistant Clone and a Silver Sulfadiazine-Resistant Clone

  Jean-Paul Pirnay;Danièle De Vos;Christel Cochez;Florence Bilocq

  227
  Citations

• Effects of sequential and simultaneous applications of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in wax moth larvae.

  Alex R. Hall;Daniel De Vos;Ville-Petri Friman;Ville-Petri Friman;Jean-Paul Pirnay

  205
  Citations

• Global Pseudomonas aeruginosa biodiversity as reflected in a Belgian river

  Jean-Paul Pirnay;Sandra Matthijs;Huri Colak;Patrice Chablain

  194
  Citations

• Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: prevalence of type II pyoverdine isolates and accumulation of pyoverdine-negative mutations.

  Daniel De Vos;Magali De Chial;Christel Cochez;Silke Jansen

  177
  Citations

• Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates.

  Jean-Paul Pirnay;Danièle De Vos;Dimitris D. Mossialos;Alain Vanderkelen

  169
  Citations

• Pseudomonas aeruginosa displays an epidemic population structure

  Jean-Paul Pirnay;Danièle De Vos;Christel Cochez;Florence Bilocq

  152
  Citations

• Stability of Staphylococcus aureus Phage ISP after Freeze-Drying (Lyophilization)

  Maia Merabishvili;Chris Vervaet;Jean-Paul Pirnay;Daniel De Vos

  150
  Citations

• Pre-adapting parasitic phages to a pathogen leads to increased pathogen clearance and lowered resistance evolution with Pseudomonas aeruginosa cystic fibrosis bacterial isolates.

  Ville‐Petri Friman;Ville‐Petri Friman;Daniel Soanes‐Brown;Pawel Sierocinski;Søren Molin

  129
  Citations